Innovative Tech Focus OpiAID specializes in leveraging advanced data science and machine learning technologies to enhance addiction treatment outcomes. Selling opportunities exist in partnering with healthcare providers seeking cutting-edge decision support tools to improve patient retention and clinical results.

Strong Recognition The company has received multiple awards and grants, including being named Best AI / Data Analytics company in North Carolina and securing significant federal funding. This recognition underscores credibility and can help facilitate engagement with healthcare institutions and investors looking for proven innovative solutions.

Funding and Growth Potential With over 2.8 million dollars in funding and a revenue range of 1 to 10 million dollars, OpiAID demonstrates strong growth potential and financial stability. Opportunities exist to collaborate with the company as it scales technology and expands its market presence in the wellness and healthcare sectors.

Market Positioning OpiAID operates in a rapidly expanding industry focused on improving addiction treatment efficacy. Its focus on opioid use disorder aligns with increasing demand for digital health solutions, creating sales opportunities with healthcare organizations, clinics, and government agencies aiming to adopt innovative treatment tools.

Strategic Collaborations Given its recognition as an innovative startup and its active participation in grants and competitions, OpiAID is likely open to strategic partnerships and pilot programs. Engaging with them can lead to joint developments, co-marketing efforts, or collaborative research ventures to enhance product offerings.